DXR SEC Filings: 8-K, 10-Q, S-3 & 424B – Daxor

Financials

TYPE

HEADLINE

FILED AT

N-CSR

Form N-CSR - Certified Shareholder Report

Aug 31, 2026

N-CSR

Form N-CSR - Certified Shareholder Report

Mar 2, 2026

N-CSR/A

Form N-CSR/A - Certified Shareholder Report: [Amend]

Dec 29, 2025

N-CSR/A

Form N-CSR/A - Certified Shareholder Report: [Amend]

Oct 15, 2025

N-CSR

Form N-CSR - Certified Shareholder Report

Aug 29, 2025

N-CSR

Form N-CSR - Certified Shareholder Report

Mar 3, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Daxor Corporation Announces Results of 2026 Annual Meeting of Shareholders

Jun 24, 2026

8-K

Daxor Corporation Closes Registered Direct Offering of Common Stock

Jan 26, 2026

8-K

Daxor Corporation Files Current Investor Presentation

Jan 23, 2026

8-K

Daxor Corporation Receives FDA Clearance for New Blood Volume Analyzer

Aug 7, 2025

8-K

Daxor Corporation Annual Meeting Results

Jul 1, 2025

8-K

Annual Meeting Elects Directors for Terms Expiring in 2025 with Detailed Voting Results

Jul 18, 2024

Prospectus

TYPE

HEADLINE

FILED AT

424B4

FIXED PRICE OFFERING - COMMON STOCK | Offering amount: $9,000,006 | Shares: 765,958 | Price: $11.750 | Bank: Lake Street Capital Markets, LLC

Jan 23, 2026

424B3

PENDING FIXED PRICE OFFERING | Bank: Lake Street Capital Markets, LLC

Jan 23, 2026

424B3

SHARE RESALE REGISTRATION | Offering amount: $25,000,000

Jan 22, 2026

497

Form 497 - Definitive materials

May 23, 2023

497

Form 497 - Definitive materials

May 19, 2023

497

Form 497 - Definitive materials

Nov 17, 2022

Registrations

TYPE

HEADLINE

FILED AT

40-8F-2/A

Form 40-8F-2/A - Application for deregistration [Rule O-2]: [Amend]

Oct 9, 2026

40-8F-2/A

Form 40-8F-2/A - Application for deregistration [Rule O-2]: [Amend]

Sep 3, 2026

40-8F-2/A

Form 40-8F-2/A - Application for deregistration [Rule O-2]: [Amend]

Jun 17, 2026

40-8F-2/A

Form 40-8F-2/A - Application for deregistration [Rule O-2]: [Amend]

May 21, 2026

N-2/A

Form N-2/A - Registration statement for closed-end investment companies: [Amend]

Dec 29, 2025

N-2/A

Form N-2/A - Registration statement for closed-end investment companies: [Amend]

Oct 20, 2025

Proxies

TYPE

HEADLINE

FILED AT

N-PX

Form N-PX - Annual Report of proxy voting record of management investment companies

Aug 31, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jun 3, 2026

N-PX

Form N-PX - Annual Report of proxy voting record of management investment companies

Sep 2, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jun 6, 2025

N-PX

Form N-PX - Annual Report of proxy voting record of management investment companies

Sep 9, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jun 21, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Jefferies John (Reporting)

Sep 1, 2026

Michel Robert J (Reporting)

Jun 25, 2026

Feldschuh Michael Richard (Reporting)

Jun 25, 2026

Feldschuh Jonathan Adam (Reporting)

Jun 25, 2026

Goudie Joy S. (Reporting)

Jun 25, 2026

Cremisi Henry D. (Reporting)

Jun 25, 2026

Other

TYPE

HEADLINE

FILED AT

N-CEN/A

Form N-CEN/A - Annual Report for Registered Investment Companies: [Amend]

Sep 24, 2026

NPORT-P

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Aug 31, 2026

NPORT-P

Form NT NPORT-P - EDGAR generated form type for a late filing of a Monthly Portfolio Investments Report on Form N-PORT (Public)

Jun 1, 2026

N-CEN/A

Form N-CEN/A - Annual Report for Registered Investment Companies: [Amend]

Apr 2, 2026

N-CEN

Form N-CEN - Annual Report for Registered Investment Companies

Mar 16, 2026

NPORT-P

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Mar 2, 2026

Daxor Corporation DXR · SEC Filings